LeafNLP Demos
Back to explore

Report #2887992

Received Mar 6, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
RI
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—OT

Symptoms (2)

Hepatitis B antibodyHepatitis B antibody negative

Symptom narrative

Hepatitis B antibody titer was low; This Literature (Spontaneous) report has been received from the authors of a published article, titled as stated below and referred to a 72 -year-old Male patient with a history of end stage renal disease and chronic positive hepatitis B core antibody since 2020. On an unknown date, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) Suspension for injection (dose, lot#, expiration date, route of administration and anatomical site were not provided) for Prophylaxis. On an unknown date, reported as " a year ago" (unknown date of contact with the patient), he received his last Hepatitis B Vaccine (Recombinant) Suspension for injection (dose, lot#, expiration date, route of administration and anatomical site were not provided) as his hepatitis B antibody titer was low (Hepatitis B antibody abnormal). It was unclear if he received any booster doses. On an unknown date, the patient experienced Hepatitis B antibody titer was low (Hepatitis B antibody abnormal). It was reported that the patient had a hepatitis B reactivation. The Authors considered the event Hepatitis B antibody abnormal to be related to Hepatitis B Vaccine (Recombinant). Batch/Lot number is being requested and will be submitted if received.

Current illness

End stage renal disease; Hepatitis B core antibody positive

Medical history

Medical History/Concurrent Conditions: Hepatitis B